Literature DB >> 28916899

Impact of surgical complications on the risk of hepatocellular carcinoma recurrence after hepatic resection.

Riccardo Pravisani1, Umberto Baccarani2, Miriam Isola3, Gianluigi Adani1, Dario Lorenzin1, Giovanni Terrosu1, Andrea Risaliti1.   

Abstract

Surgery-related morbidity has been identified as prognostic risk factor for tumor recurrence for several tumor types, but data regarding hepatocellular carcinoma (HCC) are limited and controversial. The aim of this study was to analyze the impact of surgical complications on the risk of HCC recurrence after hepatic resection (HR). A Retrospective study was conducted on a cohort of patients submitted to HR in a tertiary teaching hospital, between January 2006 and December 2015. 112 patients were submitted to HR during the study period. Cirrhosis was present in 84% of cases, with portal hypertension in 19.6%. The median MELD score was 8 (range 6-15). The median number of lesions per patient was 1 (range 1-5) with a mean diameter of 5.4 ± 3.8 cm. Major HR were performed in 18.2% of cases. Overall post-op morbidity was 48.2% with Clavien-Dindo (CD) severity score ≥3 in 15.2% of cases. The most frequent complications were infected biloma (19.6%) and liver failure (14%). HCC recurred in 48% of patients. At univariate analysis overall post-op complications (HR 2.313, p = 0.003), CD score >2 (HR 2.075, p = 0.047), post-op liver failure (HR 2.990, p = 0.007), post-op iperbilirubinemia (HR 1.151, p = 0.049), post-op bleeding (HR 2.633, p < 0.001) and infected biloma (HR 2.696, p = 0.001) were risk factors for HCC recurrence. At multivariate analysis post-op liver failure (HR 4.081, p < 0.0001) and infected biloma (HR 2.971, p < 0.0001) maintained statistical significance for HCC recurrence. Thus Major surgical complications after HR, especially post-op liver failure and infected biloma are risk factors for HCC recurrence.

Entities:  

Keywords:  HCC recurrence; Hepatic resection; Hepatocellular carcinoma; Infected biloma; Postoperative complications; Postoperative liver failure

Mesh:

Year:  2017        PMID: 28916899     DOI: 10.1007/s13304-017-0486-0

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  18 in total

Review 1.  Enhanced recovery following liver surgery: a systematic review and meta-analysis.

Authors:  Michael J Hughes; Stephen McNally; Stephen J Wigmore
Journal:  HPB (Oxford)       Date:  2014-03-24       Impact factor: 3.647

Review 2.  Comprehensive review of post-liver resection surgical complications and a new universal classification and grading system.

Authors:  Masayuki Ishii; Toru Mizuguchi; Kohei Harada; Shigenori Ota; Makoto Meguro; Tomomi Ueki; Toshihiko Nishidate; Kenji Okita; Koichi Hirata
Journal:  World J Hepatol       Date:  2014-10-27

3.  Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS).

Authors:  Nuh N Rahbari; O James Garden; Robert Padbury; Mark Brooke-Smith; Michael Crawford; Rene Adam; Moritz Koch; Masatoshi Makuuchi; Ronald P Dematteo; Christopher Christophi; Simon Banting; Val Usatoff; Masato Nagino; Guy Maddern; Thomas J Hugh; Jean-Nicolas Vauthey; Paul Greig; Myrddin Rees; Yukihiro Yokoyama; Sheung Tat Fan; Yuji Nimura; Joan Figueras; Lorenzo Capussotti; Markus W Büchler; Jürgen Weitz
Journal:  Surgery       Date:  2011-01-14       Impact factor: 3.982

4.  Prognostic significance of postoperative complications after hepatectomy for hepatocellular carcinoma.

Authors:  Yukiyasu Okamura; Shin Takeda; Tsutomu Fujii; Hiroyuki Sugimoto; Shuji Nomoto; Akimasa Nakao
Journal:  J Surg Oncol       Date:  2011-06-28       Impact factor: 3.454

5.  Postoperative complications are predictive of poor prognosis in hepatocellular carcinoma.

Authors:  Norifumi Harimoto; Ken Shirabe; Toru Ikegami; Tomoharu Yoshizumi; Takashi Maeda; Kiyoshi Kajiyama; Takeharu Yamanaka; Yoshihiko Maehara
Journal:  J Surg Res       Date:  2015-06-11       Impact factor: 2.192

6.  Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.

Authors:  Dan-Yun Ruan; Ze-Xiao Lin; Yang Li; Nan Jiang; Xing Li; Dong-Hao Wu; Tian-Tian Wang; Jie Chen; Qu Lin; Xiang-Yuan Wu
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

7.  Predictors and prognostic significance of operative complications in patients with hepatocellular carcinoma who underwent hepatic resection.

Authors:  T Kusano; A Sasaki; S Kai; Y Endo; K Iwaki; K Shibata; M Ohta; S Kitano
Journal:  Eur J Surg Oncol       Date:  2009-05-13       Impact factor: 4.424

Review 8.  Regulation of Transdifferentiation and Retrodifferentiation by Inflammatory Cytokines in Hepatocellular Carcinoma.

Authors:  Florian Cabillic; Anne Corlu
Journal:  Gastroenterology       Date:  2016-07-19       Impact factor: 22.682

9.  Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma.

Authors:  K S Chok; K K Ng; R T Poon; C M Lo; S T Fan
Journal:  Br J Surg       Date:  2009-01       Impact factor: 6.939

10.  The impact of posthepatectomy liver failure on the recurrence of hepatocellular carcinoma.

Authors:  Kohta Iguchi; Etsuro Hatano; Kenya Yamanaka; Shiro Tanaka; Kojiro Taura; Shinji Uemoto
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

View more
  5 in total

1.  Impact of Postoperative Complications on Long-Term Survival After Resection of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Junjie Kong; Guangbing Li; Jiawei Chai; Guangsheng Yu; Yong Liu; Jun Liu
Journal:  Ann Surg Oncol       Date:  2021-06-23       Impact factor: 5.344

2.  Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis.

Authors:  Joseph Kuo; Sonia Simón Serrano; Alvar Grönberg; Ramin Massoumi; Magnus Joakim Hansson; Philippe Gallay
Journal:  Front Pharmacol       Date:  2019-09-26       Impact factor: 5.810

3.  Single Large Nodule (>5 cm) Prognosis in Hepatocellular Carcinoma: Kinship with Barcelona Clinic Liver Cancer (BCLC) Stage A or B?

Authors:  Li Wan; Ding-Hui Dong; Xiao-Ning Wu; Hong-Fan Ding; Qiang Lu; Yong Tian; Xu-Feng Zhang; Wenzhi Li
Journal:  Med Sci Monit       Date:  2020-10-16

4.  Efficacy of the association liver partition and portal vein ligation for staged hepatectomy for the treatment of solitary huge hepatocellular carcinoma: a retrospective single-center study.

Authors:  Zhenfeng Deng; Zongrui Jin; Yonghui Qin; Mingqi Wei; Jilong Wang; Tingting Lu; Ling Zhang; Jingjing Zeng; Li Bao; Ya Guo; Minhao Peng; Banghao Xu; Zhang Wen
Journal:  World J Surg Oncol       Date:  2021-03-30       Impact factor: 2.754

5.  Mitochondrial apurinic/apyrimidinic endonuclease 1 enhances mtDNA repair contributing to cell proliferation and mitochondrial integrity in early stages of hepatocellular carcinoma.

Authors:  Veronica Bazzani; Arianna Barchiesi; Dorota Radecka; Riccardo Pravisani; Antonio Guadagno; Carla Di Loreto; Umberto Baccarani; Carlo Vascotto
Journal:  BMC Cancer       Date:  2020-10-07       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.